PIKOVIT 1 mg/5 mL+ 0.6 mg/5 mL+ 1 µg/5 mL+ 5 mg/5 mL+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 mL+ 100 i.j./5 mL+ 900 i.j./5 mL sirup البوسنة والهرسك - الكرواتية - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pikovit 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml sirup

krka farma d.o.o. sarajevo - askorbinska kiselina, dekspantenol, holekalciferol, nikotinamid, piridoksin, retinol, tiamin, vitamin b12, vitamin b2 - sirup - 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml - 5 ml sirupa (1 mjerna kašičica) sadrži: 900 i.j. retinol palmitat (vitamin a); 100 i.j. holekalciferol (vitamin d3); 50 mg askorbinska kiselina (vitamin c); 1 mg tiaminhidrohlorid (vitamin b1); 1 mg riboflavinfosfatnatrijum (vitamin b2); 0,6 mg vitamin b6 (piridoksinhidrohlorid); 1 mcg cijanokobalamin (vitamin b12); 5 mg nikotinamid; 2 mg dekspantenol

Biorphen 0,1 mg/ml otopina za injekciju/infuziju كرواتيا - الكرواتية - HALMED (Agencija za lijekove i medicinske proizvode)

biorphen 0,1 mg/ml otopina za injekciju/infuziju

sintetica gmbh, albersloher weg 11, münster, njemačka - fenilefrinklorid - otopina za injekciju / infuziju - 0,1 mg/ml - urbroj: 1ml otopine za injekciju/infuziju sadrži 0,1 mg fenilefrinklorida, što odgovara 0,08 mg fenilefrina

Biorphen 10 mg/ml otopina za injekciju كرواتيا - الكرواتية - HALMED (Agencija za lijekove i medicinske proizvode)

biorphen 10 mg/ml otopina za injekciju

sintetica gmbh, albersloher weg 11, münster, njemačka - fenilefrinklorid - otopina za injekciju - 10 mg/ml - urbroj: 1 ml otopine za injekciju sadrži 10 mg fenilefrinklorida, što odgovara 8,2 mg fenilefrina

LENDACIN 1g Prašak i rastvarač za rastvor za injekciju/infuziju الجبل الأسود - الكرواتية - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lendacin 1g prašak i rastvarač za rastvor za injekciju/infuziju

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - ceftriakson - prašak i rastvarač za rastvor za injekciju/infuziju - 1g

DOXORUBICIN EBEWE 50mg/25ml Koncentrat za rastvor za infuziju الجبل الأسود - الكرواتية - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

doxorubicin ebewe 50mg/25ml koncentrat za rastvor za infuziju

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - doksorubicin - koncentrat za rastvor za infuziju - 50mg/25ml

DOXORUBICIN EBEWE 10mg/5ml Koncentrat za rastvor za infuziju الجبل الأسود - الكرواتية - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

doxorubicin ebewe 10mg/5ml koncentrat za rastvor za infuziju

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - doksorubicin - koncentrat za rastvor za infuziju - 10mg/5ml

Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

lenalidomide krka d.d. novo mesto (previously lenalidomide krka)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresivi - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresivi - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 i 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 i 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

T-61 كرواتيا - الكرواتية - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

t-61

intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - embutramid; mebezonijev jodid; tetrakain hidroklorid - otopina za injekciju - pasa, mačaka, drugih malih životinja, ptica i velikih životinja

Ophtesia 4 mg/ml kapi za oko, otopina كرواتيا - الكرواتية - HALMED (Agencija za lijekove i medicinske proizvode)

ophtesia 4 mg/ml kapi za oko, otopina

agepha pharma s.r.o., diaľničná cesta 5, senec, slovačka - oksibuprokainklorid - kapi za oko, otopina - urbroj: 1 ml otopine sadrži 4 mg oksibuprokainklorida